Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 13/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | F11 | P03951 | 3/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6438914 | 0.85 | F2 (0.45) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6438918 | 0.85 | F2 (0.45) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL7702468 | 0.82 | ALDH1A1 (0.41) | F2ALDH1A1SMN1; SMN2F11PRSS1 | |
| SCHEMBL6435588 | 0.81 | F2 (0.39) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6435578 | 0.81 | F2 (0.39) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6438847 | 0.80 | F2 (0.47) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6438838 | 0.80 | F2 (0.47) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6439145 | 0.79 | F2 (0.48) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6439144 | 0.79 | F2 (0.48) | F2ALDH1A1F11PRSS1 | |
| SCHEMBL6436703 | 0.78 | F2 (0.45) | F2ALDH1A1F11PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6444672-B1 | ORAL BIOVAILABILITY; INHIBITORS OF THROMBIN AND/OR FACTOR XA; SERINE PROTEASE INHIBITOR | AKZO NOBEL N.V. (NL) | 2002-09-03 | — | — | US | disclosed |